These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26784684)

  • 1. Multiplex immunoassay for in vitro characterization of acellular pertussis antigens in combination vaccines.
    Agnolon V; Bruno C; Galletti B; Mori E; Ugozzoli M; Pergola C; O'Hagan DT; Baudner BC
    Vaccine; 2016 Feb; 34(8):1040-6. PubMed ID: 26784684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An intrinsic fluorescence method for the determination of protein concentration in vaccines containing aluminum salt adjuvants.
    Nouchikian L; Roque C; Song JY; Rahman N; Ausar SF
    Vaccine; 2018 Sep; 36(38):5738-5746. PubMed ID: 30107994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus.
    van Gageldonk PG; van Schaijk FG; van der Klis FR; Berbers GA
    J Immunol Methods; 2008 Jun; 335(1-2):79-89. PubMed ID: 18407287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of adjuvants to improve immune responses against TdaP vaccines: A preclinical evaluation of MF59 and monophosphoryl lipid A.
    Agnolon V; Bruno C; Leuzzi R; Galletti B; D'Oro U; Pizza M; Seubert A; O'Hagan DT; Baudner BC
    Int J Pharm; 2015 Aug; 492(1-2):169-76. PubMed ID: 26149936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a cell line-based in vitro assay for assessment of Diphtheria, Tetanus and acellular Pertussis (DTaP)-induced inflammasome activation.
    Vandebriel RJ; Stalpers CAL; Vermeulen JP; Remkes M; Schmelter M; Broere F; Hoefnagel MHN
    Vaccine; 2022 Sep; 40(38):5601-5607. PubMed ID: 35999078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and potency of an acellular pertussis vaccine composed of pertussis toxin, filamentous hemagglutinin, and pertactin.
    Sheu GC; Wo YY; Yao SM; Chou FY; Hsu TC; Ju CL; Cheng Y; Chang SN; Lu CH
    J Microbiol Immunol Infect; 2001 Dec; 34(4):243-51. PubMed ID: 11825003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collaborative study on a Guinea pig serological method for the assay of acellular pertussis vaccines.
    Winsnes R; Sesardic D; Daas A; Terao E; Behr-Gross ME
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):27-40. PubMed ID: 20144450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
    Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
    BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.
    Ausiello CM; Urbani F; La Sala A; Lande R; Piscitelli A; Cassone A
    Dev Biol Stand; 1997; 89():315-20. PubMed ID: 9272365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
    Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
    N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
    Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ
    Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Composition of acellular pertussis and combination vaccines: a general review.
    Jadhav SS; Gairola S
    Biologicals; 1999 Jun; 27(2):105-10. PubMed ID: 10600195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes.
    Gaillard ME; Bottero D; Errea A; Ormazábal M; Zurita ME; Moreno G; Rumbo M; Castuma C; Bartel E; Flores D; van der Ley P; van der Ark A; F Hozbor D
    Vaccine; 2014 Feb; 32(8):931-7. PubMed ID: 24397896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single radial immunodiffusion as a method for the assay of the acellular pertussis vaccine components, pertussis toxoid, filamentous haemagglutinin and pertactin.
    Xing DK; Canthaboo C; Corbel MJ; Schild GC
    Biologicals; 1998 Sep; 26(3):217-24. PubMed ID: 10208723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
    Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J
    N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of transmission electron microscopy for examination of components of acellular pertussis and combination vaccines.
    Hockley DJ; Williams L; Xing D; Corbel MJ
    Biologicals; 1999 Jun; 27(2):149-54. PubMed ID: 10600204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid ELISA-based method for screening Bordetella pertussis strain production of antigens included in current acellular pertussis vaccines.
    Barkoff AM; Guiso N; Guillot S; Xing D; Markey K; Berbers G; Mertsola J; He Q
    J Immunol Methods; 2014 Jun; 408():142-8. PubMed ID: 24925807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 13 acellular pertussis vaccines: overview and serologic response.
    Edwards KM; Meade BD; Decker MD; Reed GF; Rennels MB; Steinhoff MC; Anderson EL; Englund JA; Pichichero ME; Deloria MA
    Pediatrics; 1995 Sep; 96(3 Pt 2):548-57. PubMed ID: 7659475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass Spectrometry-Based Quantification of the Antigens in Aluminum Hydroxide-Adjuvanted Diphtheria-Tetanus-Acellular-Pertussis Combination Vaccines.
    van der Maas L; Danial M; Kersten GFA; Metz B; Meiring HD
    Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model.
    Misiak A; Leuzzi R; Allen AC; Galletti B; Baudner BC; D'Oro U; O'Hagan DT; Pizza M; Seubert A; Mills KHG
    Vaccine; 2017 Sep; 35(39):5256-5263. PubMed ID: 28823618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.